Cargando…
Heparin dosing in uninterrupted anticoagulation with dabigatran vs. warfarin in atrial fibrillation ablation: RE-CIRCUIT study
AIMS: To describe heparin dosing requirements in patients who underwent catheter ablation of atrial fibrillation with uninterrupted anticoagulation using dabigatran etexilate (dabigatran) or warfarin to attain therapeutic activated clotting time (ACT) in the RE-CIRCUIT(®) study. The RE-CIRCUIT study...
Autores principales: | Calkins, Hugh, Willems, Stephan, Verma, Atul, Schilling, Richard, Hohnloser, Stefan H, Okumura, Ken, Nordaby, Matias, Kleine, Eva, Bis, Branislav, Gerstenfeld, Edward P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781146/ https://www.ncbi.nlm.nih.gov/pubmed/30982849 http://dx.doi.org/10.1093/europace/euz057 |
Ejemplares similares
-
Regional differences in patient characteristics and outcomes during uninterrupted anticoagulation with dabigatran versus warfarin in catheter ablation of atrial fibrillation: the RE-CIRCUIT study
por: Hohnloser, Stefan H., et al.
Publicado: (2019) -
Comparison of uninterrupted anticoagulation with dabigatran etexilate or warfarin in the periprocedural period for atrial fibrillation catheter ablation: Results of the Japanese subgroup of the RE‐CIRCUIT trial
por: Yoshida, Yukihiko, et al.
Publicado: (2018) -
Uninterrupted dabigatran is safer than warfarin in patients undergoing
ablation for atrial fibrillation
por: Spartalis, Michael, et al.
Publicado: (2017) -
Effects of uninterrupted dabigatran on the intensity of anticoagulation during atrial fibrillation ablation
por: Osawa, Takumi, et al.
Publicado: (2021) -
Heparin requirements for full anticoagulation are higher for patients on dabigatran than for those on warfarin – a model-based study
por: Edrich, Thomas, et al.
Publicado: (2015)